-       Report 
- January 2024
-  100 Pages 
- Africa 
   From       €1780EUR$2,000USD£1,567GBP 
          -       Report 
- January 2024
-  80 Pages 
- China 
   From       €1335EUR$1,500USD£1,175GBP 
          -       Report 
- January 2024
-  80 Pages 
- France 
   From       €1335EUR$1,500USD£1,175GBP 
          -       Report 
- January 2024
-  80 Pages 
- Germany 
   From       €1335EUR$1,500USD£1,175GBP 
          -       Report 
- January 2024
-  80 Pages 
- India 
   From       €1335EUR$1,500USD£1,175GBP 
           -       Report 
- January 2024
-  80 Pages 
- Russia 
   From       €1335EUR$1,500USD£1,175GBP 
          -       Report 
- January 2024
-  80 Pages 
- Saudi Arabia 
   From       €1335EUR$1,500USD£1,175GBP 
          -       Report 
- January 2024
-  80 Pages 
- South Korea 
   From       €1335EUR$1,500USD£1,175GBP 
          -       Report 
- January 2024
-  80 Pages 
- United States 
   From       €1335EUR$1,500USD£1,175GBP 
            -       Report 
- December 2023
-  255 Pages 
- Global 
   From       €1112EUR$1,250USD£979GBP 
      €2225EUR$2,500USD£1,958GBP 
          -       Report 
- October 2023
-  80 Pages 
- Saudi Arabia 
   From       €1335EUR$1,500USD£1,175GBP 
          -       Report 
- October 2023
-  80 Pages 
- India 
   From       €1335EUR$1,500USD£1,175GBP 
          -       Report 
- October 2023
-  80 Pages 
- Germany 
   From       €1335EUR$1,500USD£1,175GBP 
          -       Report 
- October 2023
-  80 Pages 
- France 
   From       €1335EUR$1,500USD£1,175GBP 
          -       Report 
- October 2023
-  80 Pages 
- United States 
   From       €1335EUR$1,500USD£1,175GBP 
          -       Report 
- October 2023
-  80 Pages 
- United Kingdom 
   From       €1335EUR$1,500USD£1,175GBP 
          From       €1335EUR$1,500USD£1,175GBP 
          -       Report 
- October 2023
-  80 Pages 
- South Korea 
   From       €1335EUR$1,500USD£1,175GBP 
            -       Report 
- October 2023
-  180 Pages 
- Global 
   From       €1112EUR$1,250USD£979GBP 
      €2225EUR$2,500USD£1,958GBP 
          -       Report 
- April 2023
-  80 Pages 
- United States 
   From       €1335EUR$1,500USD£1,175GBP 
       
       The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically    more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less   Read more